Title: New Report Big Pharma Companies Current Agreement and Future Extension
1Partnering Deals and Alliances with Big Pharma
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
Published March 2014 Single User PDF US
3295 Corporate User PDF US 16495
2Partnering Deals and Alliances with Big Pharma
- Delivery of this report will take 1-3 days after
purchase. - The Partnering Deals and Alliances with Big
Pharma report provides the most comprehensive and
in-depth insight into the dealmaking interests
and activity of the worlds leading fifty big
pharma companies. - Delivery of this report will take 1-3 days after
purchase. - View the Complete report of 816 Pages
Reach us at 1 888 391 5441 sales_at_sandlerresear
ch.org
3Partnering Deals and Alliances with Big Pharma
- Partnering Deals and Alliances with Big Pharma
provides the user with the following key
benefits - Detailed partnering activity profiles for each of
the top 50 big pharma companies - Over 300 charts showing a companys dealmaking
activity since 2007, allowing quick
identification potential partners - Partnering therapy focus revealed
- Partnering activity since 2009 number of deals
per year - Full listing of partnering deals
- Activity by deal type
- Activity by industry sector
- Activity by phase of development
- Activity by technology type
- Activity by therapeutic area
Get Sample of the Report _at_ http//www.reportsnrepo
rts.com/contacts/RequestSample.aspx?name56445 .
4Partnering Deals and Alliances with Big Pharma
- Partnering Deals and Alliances with Big Pharma
provides the user with the following key
benefits - Comprehensive access to over 3,000 partnering
deals as recorded at Current Agreement, together
with contract documents if available - Insight into the terms included in a partnering
agreement, together with real world clause
examples, via contract documents - Understand the key deal terms the company has
agreed in previous deals - Undertake due diligence to assess suitability of
your proposed deal terms for partner companies - The Partnering Deals and Alliances with Big
Pharma report provides the most comprehensive and
in-depth insight into the dealmaking interests
and activity of the worlds leading fifty big
pharma companies. - This premier report provides all the information
you require to better understand big pharma
partnering.
Inquire for Discount _at_ http//www.reportsnreports.
com/contacts/Discount.aspx?name56445 .
5Partnering Deals and Alliances with Big Pharma
- One of the key aspects of partnering is finding
those companies that are potential candidates for
the development and commercialization of the next
generation of therapies. A lot of resources are
spent on finding partners, identifying their
interests and making contact to initiate
discussions. - Using this report, dealmakers will effectively
and efficiently target their partnering
activities to deliver the companys business
development objectives. Over 300 charts allow
quick understanding of each big pharma companies
dealmaking trends over the last four years. - This report contains over 3,000 links to online
copies of actual partnering deals as recorded at
Current Agreement, together with contract
documents if submitted to the Securities Exchange
Commission by bigpharma and their partners. - Contract documents provide the answers to
numerous questions about a prospective partners
flexibility on a wide range of important issues,
many of which will have a significant impact on
each partys ability to derive value from the
deal.
Delivery of this report will take 1-3 days after
purchase.
6Partnering Deals and Alliances with Big Pharma
- The initial chapters of this report provide an
orientation of big pharmas dealmaking and
business activities. - Chapter 1 provides an introduction to the report,
whilst chapter 2 lists the top 50 leading big
pharma companies based on 2012 pharmaceutical
revenues and dealmaking activity since 2009. - Chapter 3 reviews the top partnering and MA
deals of 2009-2014 according to reported deal
size. - Chapter 4 provides a summary on best practice on
how to submit an opportunity to big pharma, to
ensure building of relationships and to obtain a
prompt assessment and response from the business
development function of the prospective partner. - Chapter 5 lists forthcoming partnering events
where valuable face to face meetings with big
pharma provide a highly effective means of
obtaining interest in novel opportunities. These
events are where dealmaking gets initiated
through numerous back to back meetings.
Reach us at 1 888 391 5441 sales_at_sandlerresear
ch.org
7Partnering Deals and Alliances with Big Pharma
- Key benefits
- Partnering Deals and Alliances with Big Pharma
provides the user with the following key
benefits - Detailed partnering activity profiles for each of
the top 50 big pharma companies - Over 300 charts showing a companys dealmaking
activity since 2009, allowing quick
identification potential partners - Partnering therapy focus revealed
- Partnering activity since 2009 number of deals
per year - Full listing of partnering deals
- Activity by deal type
- Activity by industry sector
- Activity by phase of development
- Activity by technology type
- Activity by therapeutic area
Reach us at 1 888 391 5441 sales_at_sandlerresear
ch.org
8Partnering Deals and Alliances with Big Pharma
- Report scope
- Partnering Deals and Alliances with Big Pharma is
intended to provide the reader with an in-depth
understanding of the partnering activities of the
leading fifty big pharma companies worldwide,
enabling the effective assessment and selection
of partners of choice, based on the latest
knowledge of a companys partnering. - Report includes
- Partnering Deals and Alliances with Big Pharma
included - Analyzing actual company agreements allows
assessment - Benefits
- View the Complete report of 816 Pages
Reach us at 1 888 391 5441 sales_at_sandlerresear
ch.org